Physician profile
Ramy Doss
NPI 1588282925
$1,543.76
in general payments reported to CMS, 2019-2025
8 companies · $1,525 in 2025
The $1,525 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $18.32 · 2025: $1,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $990 · Food and Beverage: $359 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $990.27 |
| Food and Beverage | $359.29 |
| Education | $194.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,057.06 | 2025 | Symplicity G3 |
| Abbott Laboratories | $356.34 | 2025 | Ensite |
| Pfizer INC. | $32.06 | 2025 | |
| Alnylam Pharmaceuticals INC. | $26.17 | 2025 | Onpattro |
| Merck Sharp & Dohme LLC | $22.00 | 2025 | Verquvo |
| Amgen INC. | $18.32 | 2024 | Repatha |
| Kestra Medical Technology Services, INC. | $18.20 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $13.61 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramy Doss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.